Trial
NCT05644496
ZYNRELEF for Pain Management in Total Knee Arthroplasty
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Baptist Health South Florida
Collaborators
—
Condition
Post Operative Pain
Intervention
Bupivacaine-Meloxicam 400 Mg-12 Mg/14 mL Injectable Solution, Extended Release
Why stopped
Study discontinued due to feasibility challenges related to participant recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-28